We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PYPL icon
351
PayPal
PYPL
$51.1B
$390K 0.01%
5,000
-5,000
-50% -$334K
MLYS icon
352
Mineralys Therapeutics
MLYS
$2.38B
$376K 0.01%
31,068
-28,863
-48% -$349K
NGNE icon
353
Neurogene
NGNE
$710M
$370K 0.01%
8,827
+1,727
+24% +$67K
CC icon
354
PUT
Chemours
CC
$2.27B
$352K 0.01%
46,900
AMC icon
355
AMC Entertainment Holdings
AMC
$2.29B
$350K 0.01%
77,028
-840
-1% -$4.19K
MFA
356
MFA Financial
MFA
$915M
$342K 0.01%
26,868
-70,553
-72% -$832K
KWEB icon
357
KraneShares CSI China Internet ETF
KWEB
$5.62B
$340K 0.01%
+10,000
New +$269K
ZURA icon
358
Zura Bio
ZURA
$542M
$329K 0.01%
80,912
+7,516
+10% +$28.1K
PTON icon
359
Peloton Interactive
PTON
$2.38B
$328K 0.01%
70,000
-190,000
-73% -$747K
CORT icon
360
CALL
Corcept Therapeutics
CORT
$11.7B
$290K 0.01%
+45,000
New +$1.6M
ASAN icon
361
Asana
ASAN
$2B
$290K 0.01%
25,000
-277,500
-92% -$3.66M
NERV icon
362
Minerva Neurosciences
NERV
$207M
$286K 0.01%
107,256
+7,400
+7% +$21.5K
NCLH icon
363
PUT
Norwegian Cruise Line
NCLH
$8.89B
$283K 0.01%
233,800
CHTR icon
364
PUT
Charter Communications
CHTR
$18.8B
$269K 0.01%
8,400
BABA icon
365
Alibaba
BABA
$304B
$265K 0.01%
+2,500
New +$205K
TXN icon
366
Texas Instruments
TXN
$254B
$258K 0.01%
+1,250
New +$251K
CCL icon
367
PUT
Carnival Corporation Ltd
CCL
$39.4B
$256K 0.01%
891,500
+120,000
+16% +$2.03M
VERU icon
368
Veru
VERU
$37.1M
$254K 0.01%
32,986
+3,064
+10% +$26.4K
HOG icon
369
PUT
Harley-Davidson
HOG
$2.67B
$241K 0.01%
235,000
+135,000
+135% +$4.89M
SCYX icon
370
SCYNEXIS
SCYX
$51.6M
$239K 0.01%
20,020
+1,860
+10% +$26.3K
MPT
371
PUT
Medical Properties Trust
MPT
$2.75B
$232K 0.01%
396,500
NBR icon
372
PUT
Nabors Industries
NBR
$1.23B
$226K 0.01%
19,100
ABBV icon
373
AbbVie
ABBV
$431B
$226K 0.01%
1,146
-12,049
-91% -$2.25M
CPRI icon
374
PUT
Capri Holdings
CPRI
$1.7B
$220K 0.01%
12,600
APLS
375
DELISTED
Apellis Pharmaceuticals
APLS
$219K 0.01%
+7,603
New +$282K

Similar funds

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.